
About Lotus Diabetes Private Limited
Data last updated:
Lotus Diabetes Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the preventive healthcare segment of the healthcare sector. It was incorporated on 21 March 2012.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2012PTC233210.
The company had an authorised share capital of ₹1.5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Preeti Handa Singhal and Sandeep Singhal.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091.
As per the financials filed for FY 2017, the company reported a revenue of ₹68,719. For the same year it recorded a net loss of ₹5.64 Lakh and EBITDA of -₹5.1 Lakh.
The last known website on record is lotusdiabetes.com.
Company details
Contact details
Lotus Diabetes Private Limited's registered office is in Delhi, Delhi. Its website is lotusdiabetes.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Lotus Diabetes Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lotus Diabetes is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
Financials of Lotus Diabetes Private Limited
FY 2024 filings availableLotus Diabetes Private Limited reported revenue of ₹68,719 for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹68,719 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.1 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.64 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Lotus Diabetes Private Limited, buy the company report.
Board of directors of Lotus Diabetes Private Limited
Lotus Diabetes has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Handa Singhal Also directs: Lotus Diabetes LLP, Plasma Healthchek Diagnostics Private Limited | Director | 01 Oct 2014 | 12 Years 1 Months | As last reported |
| Sandeep Singhal | Director | 21 Mar 2012 | 14 Years 7 Months | As last reported |
| Ajay Kumar Gupta | Director | 21 Apr 2017 | 9 Years 6 Months | As last reported |
| Rupesh Kapoor | Director | 21 Mar 2012 | 14 Years 7 Months | As last reported |
Auditor
Lotus Diabetes Private Limited is audited by ATUL GOEL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL GOEL & ASSOCIATES | FY 2017 | 011641N |
Shareholding
The shareholding of Lotus Diabetes Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Lotus Diabetes Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lotus Diabetes Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lotus Diabetes Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lotus Diabetes Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lotus Diabetes Private Limited has 6 board changes on record since 2012: 4 appointments and 2 cessations. The latest: Ajay Kumar Gupta ceased to be Additional Director on 26 Sep 2017.
Frequently asked questions
Lotus Diabetes has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Lotus Diabetes was a private limited company based in Delhi, India. The company worked in preventive health services, within the healthcare industry. It was incorporated on 21 March 2012 and is registered under CIN U74900DL2012PTC233210. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Lotus Diabetes is U74900DL2012PTC233210. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lotus Diabetes had 4 directors:
- Preeti Handa Singhal - Director
- Sandeep Singhal - Director
- Ajay Kumar Gupta - Director
- Rupesh Kapoor - Director
Lotus Diabetes was incorporated on 21 March 2012. It is registered with the Registrar of Companies, Delhi.
Lotus Diabetes can be reached through the website lotusdiabetes.com. Its registered office is in Delhi, India.
The registered office of Lotus Diabetes is at 193A Pocket A Mayur Vihar Phase – II, Delhi, India – 110091.
The latest financial statements of Lotus Diabetes on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.
Lotus Diabetes operated in the healthcare industry, in the preventive health services segment.
Ajay Kumar Gupta ceased to be Additional Director on 26 Sep 2017. Ajay Kumar Gupta was appointed as Director on 21 Apr 2017. Preeti Handa Singhal ceased to be Additional Director on 26 Sep 2015. Lotus Diabetes has 6 board changes on record in total.

